As women navigate perimenopause and menopause, various physiological changes can occur throughout the body, including those that might impact eye health. Maintaining good vision is a common concern during this life stage.
Curcumin, a compound derived from turmeric, has garnered interest for its potential biological activities. This article explores the current, albeit limited, evidence regarding curcumin’s possible role in supporting eye health as women move through midlife and beyond.
Understanding Eye Health Changes in Midlife
The eyes, like other organs, undergo natural changes with age. While perimenopause and menopause are distinct phases, the broader context of aging can influence ocular health. Various conditions affecting vision are part of the global burden of disease and injuries [1].
Maintaining overall health, including eye health, is an ongoing process. Lifestyle factors and nutritional support are often considered in supporting well-being during these years.
Curcumin and Retinal Support: Early Research
Research into curcumin’s potential effects on eye health has explored its interactions at a cellular level, particularly concerning the retina. The retina is a light-sensitive tissue at the back of the eye crucial for vision.
Some studies have investigated curcumin’s involvement in specific cellular pathways relevant to retinal health. For instance, curcumin has been studied in relation to Wnt/β-catenin signaling, a pathway implicated in exudative age-related macular degeneration [2]. Additionally, curcumin’s potential protective properties for retinal pigment epithelium during autophagy inhibition in the course of retinal degeneration have been explored [3].
Further research has looked into curcumin administration in models related to age-related macular degeneration, sometimes in combination with other therapeutic approaches like adult stem cell-derived mitochondria transfer [4]. These findings are from early-stage research and require much further investigation to understand their implications for human eye health.
What the Evidence Suggests (and Doesn’t)
The current evidence regarding curcumin’s direct impact on eye health, particularly for women in perimenopause and menopause, is limited and primarily derived from cellular and preclinical studies. While these studies offer insights into potential mechanisms, they do not translate directly to clinical benefits in humans.
There is no robust clinical evidence at this time to suggest that curcumin can significantly alter the course of age-related eye conditions or directly improve vision in menopausal women. The body of evidence for curcumin’s role in supporting eye health is considered limited [5].
It’s important to differentiate between preliminary laboratory findings and established clinical applications. While the exploration of curcumin’s properties continues, definitive conclusions about its efficacy for human eye health, especially in the context of perimenopause and menopause, cannot be drawn based on the available data.
Incorporating Curcumin: Considerations for Midlife Women
For women considering curcumin supplementation, it’s essential to understand that while it is generally recognized as safe, it may interact with certain medications or have mild side effects. Bioavailability is also a key factor, as curcumin can be poorly absorbed on its own.
As with any supplement, discussing its use with a healthcare provider is recommended, particularly for those with existing health conditions or who are taking other medications. This is especially true during perimenopause and menopause when hormonal shifts can influence overall health.
References
- Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet (London, England), 2025
- Curcumin and Wnt/β‑catenin signaling in exudative age‑related macular degeneration (Review). International journal of molecular medicine, 2022
- Curcumin as a Perspective Protection for Retinal Pigment Epithelium during Autophagy Inhibition in the Course of Retinal Degeneration. Current neuropharmacology, 2023
- Therapeutic potential of adult stem cells-derived mitochondria transfer combined with curcumin administration into ARPE-19 cells in age-related macular degeneration model. Tissue & cell, 2025
- A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical Supplementation. Cureus, 2026
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
